Lv71
5000 积分 2021-09-12 加入
Discovery of FHD-286, a First-in-Class, Orally Bioavailable, Allosteric Dual Inhibitor of the Brahma Homologue (BRM) and Brahma-Related Gene 1 (BRG1) ATPase Activity for the Treatment of SWItch/Sucrose Non-Fermentable (SWI/SNF) Dependent Cancers
10个月前
已完结
Engineered antibody Fc variant with selectively enhanced Fc RIIb binding over both Fc RIIaR131 and Fc RIIaH131
10个月前
已完结
Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulation
10个月前
已完结
Discovery of ABBV-3373, an Anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody Drug Conjugate
11个月前
已完结
Peptide–Drug Conjugates with Different Linkers for Cancer Therapy
11个月前
已完结
Evaluation of Double Self-Immolative Linker-Based Antibody–Drug Conjugate FDA022-BB05 with Enhanced Therapeutic Potential
11个月前
已完结
MORAb-003, a fully humanized monoclonal antibody against the folate receptor alpha, for the potential treatment of epithelial ovarian cancer
1年前
已关闭
Engineered human soluble calcium-activated nucleotidase inhibits coagulation in vitro and thrombosis in vivo
1年前
已完结
Site-Directed Mutagenesis of Human Endothelial Cell Ecto-ADPase/Soluble CD39: Requirement of Glutamate 174 and Serine 218 for Enzyme Activity and Inhibition of Platelet Recruitment
1年前
已完结
皖公网安备34019202002308
